| Market Cap | — | |
| Enterprise Value | — | |
| Revenue | £2.62B | +22.0% |
| Gross Profit | — | — |
| EBITDA | £1.57B | +47.2% |
| Net Income | £586.8M | +121.7% |
| Diluted EPS | £0.86 | +121.7% |
| Free Cash Flow | -£110.2M | — |
| DPS (FY2026) | — |
| Trailing yield | — |
| Payout ratio | — |
| Growth streak | — |
| 5y DPS growth | — |
| Fiscal year | DPS | YoY | Basis |
|---|---|---|---|
| FY20262026-03-31 | — | — | reported |
| FY20252025-03-31 | — | — | reported |
| FY20242024-03-31 | — | — | reported |
| FY20232023-03-31 | — | — | reported |
| Ratio | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Trend · 6y | vs own | vs sector |
|---|---|---|---|---|---|---|---|---|---|
| ▾Margins | |||||||||
| Operating Margin | 33.30% | 32.75% | 24.43% | 24.63% | 29.44% | 42.02% | 92% | 90% | |
| EBITDA Margin | 56.66% | 55.20% | 45.80% | 45.46% | 49.75% | 60.04% | 92% | 91% | |
| NOPAT Margin | 27.40% | 0.00% | 19.53% | 18.39% | 21.95% | 31.65% | 92% | 87% | |
| Net Margin | 25.08% | −3.05% | 11.36% | 6.51% | 12.34% | 22.43% | 75% | 83% | |
| FCF Margin | 13.77% | 17.47% | 6.19% | −0.23% | −3.28% | −4.21% | 8% | 46% | |
| FCFF Margin | 18.65% | 17.47% | 17.83% | 14.68% | 9.64% | 7.76% | 8% | 64% | |
| FCFE Margin | −25.14% | −19.13% | −9.23% | −12.97% | −32.71% | −20.77% | 42% | 16% | |
| OCF Margin | 47.53% | 50.16% | 43.65% | 38.22% | 42.80% | 52.82% | 92% | 92% | |
| Capex Intensity | 33.76% | 32.69% | 37.46% | 38.45% | 46.08% | 57.03% | 92% | 86% | |
| ▸Returns on Capital · 6 ratios | |||||||||
| ▸DuPont factors (ROE drivers) · 4 ratios | |||||||||
| ▸Earnings quality · 7 ratios | |||||||||
| ▸Liquidity & coverage · 9 ratios | |||||||||
| ▸Leverage · 9 ratios | |||||||||
| ▸Working capital · 3 ratios | |||||||||
| ▸Capital allocation · 5 ratios | |||||||||
| ▸Other · 1 ratios | |||||||||
The five drivers multiply to 27.2% vs reported ROE 27.7%. High ROE from margin and turnover is earned; from the equity multiplier it is borrowed.
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Revenue | £1.81B | £1.86B | £1.80B | £1.95B | £2.15B | £2.62B |
| YoY % | +3.0% | -3.1% | +8.1% | +10.0% | +22.0% | |
| Total Operating Expenses | £1.21B | £1.25B | £1.36B | £1.47B | £1.51B | £1.52B |
| YoY % | +3.9% | +8.8% | +7.8% | +3.0% | +0.2% | |
| Operating Income | £602.1M | £610.0M | £440.8M | £480.2M | £631.5M | £1.10B |
| YoY % | +1.3% | -27.7% | +8.9% | +31.5% | +74.1% | |
| Interest Expense | £107.2M | £187.8M | £262.7M | £389.3M | £371.9M | £415.7M |
| YoY % | +75.2% | +39.9% | +48.2% | -4.5% | +11.8% | |
| Equity Method Income | -£9.3M | -£1.8M | £0 | -£4.1M | -£10.8M | -£4.6M |
| Pretax Income | £551.0M | £439.9M | £256.3M | £170.0M | £355.0M | £779.0M |
| YoY % | -20.2% | -41.7% | -33.7% | +108.8% | +119.4% | |
| Income Tax | £97.6M | £496.7M | £51.4M | £43.1M | £90.3M | £192.2M |
| YoY % | +408.9% | -89.7% | -16.1% | +109.5% | +112.8% | |
| Net Income (incl. NCI) | £453.4M | -£56.8M | £204.9M | £126.9M | £264.7M | £586.8M |
| YoY % | -38.1% | +108.6% | +121.7% | |||
| EPS (Basic) | £66.50 | -£0.08 | £0.30 | £0.19 | £0.39 | £0.86 |
| YoY % | -38.0% | +108.6% | +121.9% | |||
| EPS (Diluted) | £66.30 | -£0.08 | £0.30 | £0.19 | £0.39 | £0.86 |
| YoY % | -38.0% | +108.1% | +121.7% |
The sector classification is SIC-derived, not official GICS. Statement lines are XBRL facts as filed with the company's home regulator (SEC EDGAR for US filers; ESEF/EDINET and other national regulators for foreign filers); ratios and other derived figures are computed from them. A blank cell means the tag was absent — never imputed.
| FY20222022-03-31 | — | — | reported |
| FY20212021-03-31 | — | — | reported |
